These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5076477)

  • 41. [Clinical-psychiatric observations with noxiptilin in depressive syndromes].
    Hildebrandt HJ
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:905+. PubMed ID: 5819773
    [No Abstract]   [Full Text] [Related]  

  • 42. [A study of the therapeutic effect of an insidon preparation].
    Volkova RP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(2):279-83. PubMed ID: 5786257
    [No Abstract]   [Full Text] [Related]  

  • 43. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 44. [Lithium therapy in the prevention of cyclothymic psychoses].
    Lenz H; Pürgyi P
    Wien Med Wochenschr; 1971 Jun; 121(25):522-4. PubMed ID: 5129948
    [No Abstract]   [Full Text] [Related]  

  • 45. A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Toso M; Valori C; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):249-55. PubMed ID: 7309298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Behavior of the hemorrheological pattern in subjects with essential hypertension treated with beta-blocking agents. II. Metoprolol and oxprenolol].
    Caimi G; Frazzetta F; Capobianco D; Catania A; Francavilla G; Sarno A
    Clin Ter; 1982 Nov; 103(4):383-8. PubMed ID: 7151384
    [No Abstract]   [Full Text] [Related]  

  • 47. [On high-dosage parenteral niamid treatment of depressive syndromes].
    Cornu F; Hodel J
    Nervenarzt; 1965 Dec; 36(12):515-8. PubMed ID: 5334474
    [No Abstract]   [Full Text] [Related]  

  • 48. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of oxprenolol on blood pressure, pulmonary ventilatory function and myocardial contractility in hypertensive patients.
    Schlesinger Z; Barzilay J
    Isr J Med Sci; 1980 Jun; 16(6):420-5. PubMed ID: 7399873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Unexpected therapeutic effects of tybamate in psychoses].
    Turns D; Denber HC; Turns CN
    Ann Med Psychol (Paris); 1968 Jul; 2(2):216-20. PubMed ID: 5684178
    [No Abstract]   [Full Text] [Related]  

  • 51. Controlled trial of speech therapy versus oxprenolol for stammering.
    Rustin L; Kuhr A; Cook PJ; James IM
    Br Med J (Clin Res Ed); 1981 Aug; 283(6290):517-9. PubMed ID: 6790048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of lithium salts in psychiatric disorders.
    Gershon S
    Dis Nerv Syst; 1968 Jan; 29(1):51-5. PubMed ID: 5689007
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of moderate salt restriction in hypertensive patients treated with oxprenolol or chlorthalidone.
    Pollavini G; Comi D; Grillo C; Lombardo M; Mantero O; Minetti L; Selvini A; Suppa G
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):451-5. PubMed ID: 6490228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
    Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
    G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
    [No Abstract]   [Full Text] [Related]  

  • 55. [Evaluation of a delayed-action beta blocker by 24-hour ambulatory recording of the arterial pressure].
    Campanini C; Adamec R; Barthélémy JC; Mérier G
    Schweiz Med Wochenschr; 1984 Jan; 114(1):19-24. PubMed ID: 6695162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of acute schizophrenic psychosis with beta-adrenergic blocking agents (author's transl)].
    Rackensperger W; Gaupp R; Mattke DJ; Schwarz D; Stutte KH
    Arch Psychiatr Nervenkr (1970); 1974 Jun; 219(1):29-36. PubMed ID: 4152285
    [No Abstract]   [Full Text] [Related]  

  • 57. Autonomic reactions in relation to psychotropic drugs.
    Hsu JJ; Yap AT
    Dis Nerv Syst; 1967 May; 28(5):304-10. PubMed ID: 6025269
    [No Abstract]   [Full Text] [Related]  

  • 58. [Report on clinical trials of a new neuroleptic drug].
    Stucke W
    Med Welt; 1969 Feb; 7():356-9. PubMed ID: 5801526
    [No Abstract]   [Full Text] [Related]  

  • 59. [Lithium in periodic psychoses. Report on 10 years in 34 persons].
    Beloncle M; Martin A; Masson JM; Voisinet C
    Ann Med Psychol (Paris); 1982 Mar; 140(3):369-74. PubMed ID: 6814321
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of the chronic administration of oxprenolol on the aortic wall of the normotensive and hypertensive rats.
    Pauletto P; Terribile Wiel Marin V; Santandrea S; Scannapieco G; Vescovo G; Dario C; Pessina AC
    Boll Soc Ital Biol Sper; 1983 May; 59(5):667-73. PubMed ID: 6882565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.